MetaVia expands at-the-market stock offering to $4 million

MetaVia Inc. filed a prospectus supplement dated July 2, 2026 to amend an existing at-the-market stock sale arrangement. The original filing covered an offer and sale of common stock with an aggregate offering price of up to $2,300,000, made under an At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc.¹

As of the date of the new filing, MetaVia had sold an aggregate of $2,126,303 of shares of its common stock through Ladenburg under the Sales Agreement.¹ With that amount close to the original ceiling, the company filed the supplement to amend the initial ATM prospectus and the accompanying prospectus to raise the eligible offering amount, registering the offer and sale of up to an aggregate offering price of $4,000,000 in common stock.¹

MetaVia's shares trade on the Nasdaq Capital Market under the ticker "MTVA," and the last reported sale price on July 1, 2026 was $1.45 per share.¹ For registration purposes, the aggregate market value of the company's common stock held by non-affiliates was calculated at $18,438,694, based on 4,789,271 shares held by non-affiliates and a $3.85 per share price recorded on May 22, 2026.¹

The filing notes a regulatory limit on how much MetaVia can raise: under General Instruction I.B.6 of Form S-3, the company may not sell securities in a public primary offering exceeding more than one-third of its public float in any 12-month period, as long as its public float stays below $75,000,000.¹ Over the trailing twelve months ending with the supplement date, MetaVia sold an aggregate of $2,126,303 of common stock under that same Form S-3 instruction.¹